Advanced Cancer Testing at WellSpot IV
Personalized Cancer Insight Through Advanced Blood Testing
Advanced Cancer Testing uses cutting edge blood tests to screen for cancer early, track circulating tumor cells, and guide a personalized treatment plan based on your unique cancer profile.
These tests provide deeper insight than traditional screening and can be used alongside conventional oncology care or integrative treatment plans.
Earlier detection of progression, resistance, or recurrence before imaging
Ongoing monitoring of cancer cell activity
Personalized treatment guidance based on your cells
What Is Advanced Cancer Testing?
Cancer often develops and evolves long before symptoms appear or imaging detects changes. Standard labs and scans can miss critical insights into cancer cell activity, behavior, and genetic drivers.
Advanced Cancer Testing analyzes circulating cancer cells through specialized blood testing, allowing for earlier risk detection, real-time monitoring, and personalized treatment guidance based on how your specific cancer cells respond to different therapies.
How Advanced Cancer Testing Helps
Screens for cancer risk before symptoms appear
Detects circulating tumor cells in the bloodstream
Monitors cancer activity over time
Evaluates treatment effectiveness
Guides personalized IV and supplement support
Supports integrative and traditional cancer care
Most Popular Service
RGCC Onconomics Plus
Our most advanced cancer intelligence panel, the RGCC Onconomics Plus test functions like a culture and sensitivity analysis for your personal cancer cells. Using specialized blood testing, it evaluates cancer cell activity, genetics, and how your specific cells respond to chemotherapy agents, targeted medications, and integrative therapies.
Benefits include:
Ongoing monitoring of circulating cancer cell activity
Personalized treatment guidance based on medication, chemotherapy, radiation, and supplement sensitivity
Actionable insights for oral, IV, and injectable therapies
Earlier detection of resistance, progression, or treatment response
This allows for truly precision-based cancer care — tailored to your biology, not generalized protocols.
Advanced Cancer Testing Menu
-
RGCC Onco-D-Clare (Cancer Screening)
The Onco-D-Clare goes beyond traditional screening, aiming to detect cancer at its earliest stages. This test screens for cancer and can establish your cancer risk before your body shows any signs. Over 90 genes are analyzed with a comprehensive gene expression profile.
-
RGCC Oncotrace
This test allows patients with known cancer present in the body to evaluate for Circulating Tumor Cells (CTCs), phenotypes, and stemness markers (Activity status of cancer cells) via a blood analysis. This test is usually recommended to establish a baseline and can be used for ongoing monitoring to test for treatment effectiveness. If on chemotherapy, we recommend waiting 7 to 21 days from the last chemo dose to take the test.
-
RGCC OncoTrail
This test is for patients with an active specific cancer diagnosis (Breast Cancer, Colon cancer, GI cancer, Melanoma cancer, Lung Cancer, Sarcoma Cancer, or Prostate cancer). Results provide crucial information on the presence of Circulating Tumor Cells (CTCs) and their concentration in patients with the above specific types of cancers. Oncotrail RGCC can establish a baseline of your cancer status at the beginning of treatment and can be used for follow-up to determine effectiveness of treatments. This test includes CTCs, Stemness markers, and phenotype markers.
-
RGCC Onconomics Plus (Comprehensive Treatment Testing)
This test determines the effectiveness of 90+ Chemotherapeutic agents and target therapies on your cancer cells. Additionally, this tests for effectiveness of 50+ natural substances on your specific cancer cells, this allows for a personalized IV and supplement treatment plan.This can be added to whatever you may be currently doing in a traditional cancer treatment setting. Includes: Circulating Tumor Cells (CTCs), Genetic and physiological expressions of your cancer cells as well as the above sensitivity testing.
Not Sure What to Choose?
Call us at (918) 265-4811. Our medical providers will guide you to the best option for your needs.
How It Works
Step one.
Schedule an Cancer Care Initial Consultation
We help determine which RGCC test fits your situation and goals.
Step two.
Complete the Blood Draw
Testing is done through a simple blood sample.
Step three.
Review Results and Create a Plan
Results are used to gather data on your unique cancer markers and genetics, guide integrative therapy planning, and monitor the progress through your journey.
Ready to get clear answers?
Advanced Cancer Testing provides insight, clarity, and direction when you need it most.
We have Cancer consultation services to help evaluate your case, plan for the best lab options, and get you on the path to well.
Related Articles
FAQs
-
No. The Onco D’Clare or the Oncotrace could be used for early screening and risk assessment.
-
Yes. These tests and our IV therapies are often used as part of integrative cancer care program
-
Results typically return within 10 to 15 business days depending on the test.
-
These tests are designed to inform care and be supportive of integrative measures, not replace oncology treatment.
-
For an active diagnosis, we generally recommend repeating the cancer tumor cell markers with the OncoTrace or OncoTrail every 3 to 4 months. Over time patients, usually reduce these to every 6 months or longer once in remission.